BRIEF-GSK seeks EU approval for additional indication of ITP drug

BRIEF-GSK seeks EU approval for additional indication of ITP drug

Feb 6 (Reuters) – GlaxoSmithKline Plc : * GSK announces EU regulatory submission seeking additional indication for eltrombopag (Revolade). * EMA submission includes registration of a new 25 mg powder for oral suspension formulation for eltrombopag, …

5
Like
Save

Comments

Write a comment

*